Niowave
Niowave, based in Lansing, US, is a domestic provider of medical and industrial radioisotopes.
Founded
2005Niowave, based in Lansing, US, is a domestic provider of medical and industrial radioisotopes.
Niowave, founded in Lansing, US, is dedicated to the production of medical and industrial radioisotopes. Their core mission is to manufacture radioisotopes that cure cancer and save lives. Utilizing a superconducting linear accelerator (linac) instead of a nuclear reactor, Niowave offers a range of alpha, beta, and gamma sources from uranium and radium. Their innovative approach not only enhances safety but also ensures a reliable domestic supply of critical isotopes for medical and industrial applications.
Notable figures associated with Niowave include its founders and key investors who have supported the company's pioneering technology. The company has achieved significant milestones, including establishing a robust inventory of radioisotopes and contributing to advancements in cancer treatment. Niowave's impact is profound, providing essential materials that support life-saving medical procedures and industrial processes, thereby reinforcing their vision of improving health outcomes and advancing scientific progress.
Companies similar to Niowave include Northwest Medical Isotopes, Alpha Source, NorthStar Medical Radioisotopes and Arizona Isotope Science Research.
Niowave was founded in 2005.
Niowave's headquarters is located in Lansing, MI, US.
Niowave's most recent funding round was for $500k (USD) in April 2023.
As of Apr 11, 2023, Niowave has disclosed funding of $5.2M (USD). Undisclosed round amounts are excluded.
Niowave has 101 employees as of Feb 5, 2024.
Arizona Isotope Science Research
azisotopes.org
